phenol has been researched along with MS (Multiple Sclerosis) in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We previously reported that relapsing remitting multiple sclerosis patients treated with dimethyl fumarate have a prominent depletion of the gut microbiota, thereby suggesting that studying the composition of plasma and CSF samples from these patients may help to identify microbially derived metabolites." | 4.12 | Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma. ( Amatruda, M; Button, J; Casaccia, P; Edwards, K; Frazier, C; Inbar, B; Kiebish, MA; Kim-Schulze, S; Lublin, F; Ntranos, A; Park, HJ; Tolstikov, V; Wentling, M, 2022) |
| "Treatment of spasticity poses a major challenge given the complex clinical presentation and variable efficacy and safety profiles of available drugs." | 2.53 | Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper. ( Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ntranos, A | 1 |
| Park, HJ | 1 |
| Wentling, M | 1 |
| Tolstikov, V | 1 |
| Amatruda, M | 1 |
| Inbar, B | 1 |
| Kim-Schulze, S | 1 |
| Frazier, C | 1 |
| Button, J | 1 |
| Kiebish, MA | 1 |
| Lublin, F | 1 |
| Edwards, K | 1 |
| Casaccia, P | 1 |
| Otero-Romero, S | 1 |
| Sastre-Garriga, J | 1 |
| Comi, G | 1 |
| Hartung, HP | 1 |
| Soelberg Sørensen, P | 1 |
| Thompson, AJ | 1 |
| Vermersch, P | 1 |
| Gold, R | 1 |
| Montalban, X | 1 |
| Ewing, R | 1 |
| Choa, B | 1 |
| Shuttleworth, KE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of EXOPULSE Mollii Suit on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis.[NCT05912595] | 36 participants (Anticipated) | Interventional | 2023-05-18 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phenol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diaze | 2016 |
2 other studies available for phenol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
Topics: Animals; Biomarkers; Dimethyl Fumarate; Humans; Indican; Multiple Sclerosis; Multiple Sclerosis, Rel | 2022 |
Pelvic evoked responses.
Topics: Adult; Aged; Anal Canal; Electromyography; Evoked Potentials; Female; Humans; Middle Aged; Multiple | 1983 |